UPDATED RESULTS OF ARIEL2, A PHASE 2 OPEN-LABEL STUDY TO IDENTIFY OVARIAN CANCER PATIENTS LIKELY TO RESPOND TO RUCAPARIB

I McNeish, RL Coleman, A Oza, G Konecny, DM O'Malley, G Kichenadasse, CL Scott, A Oaknin, A Floquet, D Park, JD Brenton, K Lin, S Shetty, H Giordano, M Raponi, L Rolfe, E Swisher